Skip to main content

Displaying 641 - 660 of 2210

Pfizer/Mylan, In the Matter of

Pharmaceutical companies Pfizer Inc. and Mylan N.V. have agreed to divest assets and abide by other conditions to settle Federal Trade Commission charges that the proposed combination of Upjohn Inc. and Mylan N.V. will harm current or future competition in ten generic drug markets. The FTC’s complaint alleges that the proposed combination would harm current U.S. competition in seven product markets by reducing the number of existing suppliers, and that it would harm future U.S. competition in three additional product markets. The proposed consent order requires divestitures in all 10 markets.

Type of Action
Administrative
Last Updated
FTC Matter/File Number
191 0182
Docket Number
C-4727
Case Status
Pending

FTC Publishes Annual Performance Report

Date
The Federal Trade Commission published its Fiscal Year 2020 Performance Report as required under the Government Performance and Results Modernization Act of 2010. The report documents the progress...

CoStar Group / RentPath Holdings, In the Matter of

The Federal Trade Commission filed an administrative complaint and authorized a suit in federal court to block internet listing services provider CoStar Group Inc.’s proposed $587.5 million acquisition of competitor RentPath Holdings, Inc. The complaint alleged that the acquisition would significantly increase concentration in the already highly concentrated markets for internet listing services advertising for large apartment complexes in 49 individual metropolitan areas across the United States. On Dec. 31, 2020, the FTC issued a statement on the parties’ announcement that they had abandoned the acquisition.

Type of Action
Administrative
Last Updated
FTC Matter/File Number
201 0061
Docket Number
9398
Case Status
Closed